Health product recall

Venlafaxine XR Product Recall (2019-12-20)

Starting date:
December 20, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-71949

Last updated: 2019-12-23

Summary

  • Product:
    1. Venlafaxine XR 37.5 mg Capsule
    2. Teva-Venlafaxine XR 150 mg Capsule
  1. Venlafaxine XR 37.5 mg Capsule
  2. Teva-Venlafaxine XR 150 mg Capsule

Reason

The dissolution is out of trend in the affected lot.

Depth of distribution

Healthcare Establishments, Retailers

Affected products

  1. Venlafaxine XR 37.5 mg Capsule

DIN, NPN, DIN-HIM

DIN 02354713

Dosage form

Capsule (Extended Release)

Strength

Venlafaxine hydrochloride 37.5 mg

Lot or serial number

W05930

Companies

Recalling Firm
Sanis Health
243 Consumers Road
Toronto
M2J 4W8
Ontario
CANADA
Marketing Authorization Holder
Sanis Health
243 Consumers Road
Toronto
M2J 4W8
Ontario
CANADA

B. Teva-Venlafaxine XR 150 mg Capsule

DIN, NPN, DIN-HIM

DIN 02275058

Dosage form

Capsule (Extended Release)

Strength

Venlafaxine hydrochloride 150 mg

Lot or serial number

W07930

Companies

Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: